Reverse transcription polymerase chain reaction (RT-PCR) is a popular in vitro method and has an important application in the medical science and biomaterial industry.听DNA: RNA is utilized as a template for reverse transcription.听Reverse transcriptase enzyme uses mRNA to produce cDNA, a single stranded DNA.听This process is known as reverse transcription.听In a further process, the DNA polymerase converts single stranded cDNA into double stranded DNA, which could be used as a template for PCR reaction.听Reverse transcription polymerase chain reaction is utilized in a laboratory to study gene expression, in the diagnosis of genetic diseases, and in pharmacotherapy.听RT-PCR is primarily used to measure mRNA level and the surface proteins and is feasible in the clinical laboratories.听RT-PCR is used in detecting the mRNAs, pre-mRNAs, non-coding RNA, and other types of RNA.听RT-PCR requires buffer, thermocyclers, nucleotides, template, and enzyme for constructing RT-PCR products.听RT-PCR is used as a diagnostic tool for severe acute respiratory syndrome, including Coronavirus indication.听RT-PCR test is a rapid and reliable diagnostic assay for detecting coronavirus disease.
The global market for Reverse Transcription Polymerase Chain Reaction Kits was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Reverse Transcription Polymerase Chain Reaction Kits was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Reverse Transcription Polymerase Chain Reaction Kits was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Reverse Transcription Polymerase Chain Reaction Kits was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Reverse Transcription Polymerase Chain Reaction Kits include Roche, Merck(Sigma-Aldrich), Thermo Fisher Scientific, Qiagen N.V., Meridian Bioscience, Takara Bio Inc, Agilent Technologies, Abbott Laboratories and Altona Diagnostics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Reverse Transcription Polymerase Chain Reaction Kits, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Reverse Transcription Polymerase Chain Reaction Kits by region & country, by Type, and by Application.
The Reverse Transcription Polymerase Chain Reaction Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reverse Transcription Polymerase Chain Reaction Kits.
麻豆原创 Segmentation
By Company
Roche
Merck(Sigma-Aldrich)
Thermo Fisher Scientific
Qiagen N.V.
Meridian Bioscience
Takara Bio Inc
Agilent Technologies
Abbott Laboratories
Altona Diagnostics
Bio-Rad Laboratories
Promega Corporation
Enzo Life Sciences, Inc
Cole-Parmer
Bioneer Corporation
Mylab Discovery Solutions
Biom茅rieux S.A
Segment by Type:
Quantitative Reverse Transcription Polymerase Chain Reaction Kits
Digital Reverse Transcription Polymerase Chain Reaction Kits
Segment by Application
Hospitals
Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Reverse Transcription Polymerase Chain Reaction Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Reverse Transcription Polymerase Chain Reaction Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Reverse Transcription Polymerase Chain Reaction Kits in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Reverse Transcription Polymerase Chain Reaction Kits Product Introduction
1.2 Global Reverse Transcription Polymerase Chain Reaction Kits 麻豆原创 Size Forecast
1.2.1 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value (2019-2030)
1.2.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume (2019-2030)
1.2.3 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Price (2019-2030)
1.3 Reverse Transcription Polymerase Chain Reaction Kits 麻豆原创 Trends & Drivers
1.3.1 Reverse Transcription Polymerase Chain Reaction Kits Industry Trends
1.3.2 Reverse Transcription Polymerase Chain Reaction Kits 麻豆原创 Drivers & Opportunity
1.3.3 Reverse Transcription Polymerase Chain Reaction Kits 麻豆原创 Challenges
1.3.4 Reverse Transcription Polymerase Chain Reaction Kits 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Reverse Transcription Polymerase Chain Reaction Kits Players Revenue Ranking (2023)
2.2 Global Reverse Transcription Polymerase Chain Reaction Kits Revenue by Company (2019-2024)
2.3 Global Reverse Transcription Polymerase Chain Reaction Kits Players Sales Volume Ranking (2023)
2.4 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Company Players (2019-2024)
2.5 Global Reverse Transcription Polymerase Chain Reaction Kits Average Price by Company (2019-2024)
2.6 Key Manufacturers Reverse Transcription Polymerase Chain Reaction Kits Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Reverse Transcription Polymerase Chain Reaction Kits Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Reverse Transcription Polymerase Chain Reaction Kits
2.9 Reverse Transcription Polymerase Chain Reaction Kits 麻豆原创 Competitive Analysis
2.9.1 Reverse Transcription Polymerase Chain Reaction Kits 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Reverse Transcription Polymerase Chain Reaction Kits Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reverse Transcription Polymerase Chain Reaction Kits as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Quantitative Reverse Transcription Polymerase Chain Reaction Kits
3.1.2 Digital Reverse Transcription Polymerase Chain Reaction Kits
3.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Type
3.2.1 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value, by Type (2019-2030)
3.2.3 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value, by Type (%) (2019-2030)
3.3 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Type
3.3.1 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume, by Type (2019-2030)
3.3.3 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume, by Type (%) (2019-2030)
3.4 Global Reverse Transcription Polymerase Chain Reaction Kits Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Diagnostic Centers
4.1.3 Research Laboratories & Academic Institutes
4.1.4 Pharmaceutical & Biotechnology Companies
4.1.5 Others
4.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Application
4.2.1 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value, by Application (2019-2030)
4.2.3 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value, by Application (%) (2019-2030)
4.3 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Application
4.3.1 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume, by Application (2019-2030)
4.3.3 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume, by Application (%) (2019-2030)
4.4 Global Reverse Transcription Polymerase Chain Reaction Kits Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Region
5.1.1 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Region (2019-2024)
5.1.3 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Region (2025-2030)
5.1.4 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Region (%), (2019-2030)
5.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Region
5.2.1 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Region (2019-2024)
5.2.3 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Region (2025-2030)
5.2.4 Global Reverse Transcription Polymerase Chain Reaction Kits Sales Volume by Region (%), (2019-2030)
5.3 Global Reverse Transcription Polymerase Chain Reaction Kits Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
5.4.2 North America Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
5.5.2 Europe Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
5.6.2 Asia Pacific Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
5.7.2 South America Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
5.8.2 Middle East & Africa Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Reverse Transcription Polymerase Chain Reaction Kits Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Reverse Transcription Polymerase Chain Reaction Kits Sales Value
6.2.1 Key Countries/Regions Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
6.2.2 Key Countries/Regions Reverse Transcription Polymerase Chain Reaction Kits Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
6.3.2 United States Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
6.4.2 Europe Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
6.5.2 China Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Type (%), 2023 VS 2030
6.5.3 China Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
6.6.2 Japan Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
6.7.2 South Korea Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
6.8.2 Southeast Asia Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Reverse Transcription Polymerase Chain Reaction Kits Sales Value, 2019-2030
6.9.2 India Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Type (%), 2023 VS 2030
6.9.3 India Reverse Transcription Polymerase Chain Reaction Kits Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.1.5 Roche Recent Development
7.2 Merck(Sigma-Aldrich)
7.2.1 Merck(Sigma-Aldrich) Company Information
7.2.2 Merck(Sigma-Aldrich) Introduction and Business Overview
7.2.3 Merck(Sigma-Aldrich) Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck(Sigma-Aldrich) Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.2.5 Merck(Sigma-Aldrich) Recent Development
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Information
7.3.2 Thermo Fisher Scientific Introduction and Business Overview
7.3.3 Thermo Fisher Scientific Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Thermo Fisher Scientific Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.3.5 Thermo Fisher Scientific Recent Development
7.4 Qiagen N.V.
7.4.1 Qiagen N.V. Company Information
7.4.2 Qiagen N.V. Introduction and Business Overview
7.4.3 Qiagen N.V. Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Qiagen N.V. Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.4.5 Qiagen N.V. Recent Development
7.5 Meridian Bioscience
7.5.1 Meridian Bioscience Company Information
7.5.2 Meridian Bioscience Introduction and Business Overview
7.5.3 Meridian Bioscience Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Meridian Bioscience Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.5.5 Meridian Bioscience Recent Development
7.6 Takara Bio Inc
7.6.1 Takara Bio Inc Company Information
7.6.2 Takara Bio Inc Introduction and Business Overview
7.6.3 Takara Bio Inc Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Takara Bio Inc Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.6.5 Takara Bio Inc Recent Development
7.7 Agilent Technologies
7.7.1 Agilent Technologies Company Information
7.7.2 Agilent Technologies Introduction and Business Overview
7.7.3 Agilent Technologies Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Agilent Technologies Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.7.5 Agilent Technologies Recent Development
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Information
7.8.2 Abbott Laboratories Introduction and Business Overview
7.8.3 Abbott Laboratories Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Abbott Laboratories Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.8.5 Abbott Laboratories Recent Development
7.9 Altona Diagnostics
7.9.1 Altona Diagnostics Company Information
7.9.2 Altona Diagnostics Introduction and Business Overview
7.9.3 Altona Diagnostics Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Altona Diagnostics Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.9.5 Altona Diagnostics Recent Development
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Company Information
7.10.2 Bio-Rad Laboratories Introduction and Business Overview
7.10.3 Bio-Rad Laboratories Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Bio-Rad Laboratories Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.10.5 Bio-Rad Laboratories Recent Development
7.11 Promega Corporation
7.11.1 Promega Corporation Company Information
7.11.2 Promega Corporation Introduction and Business Overview
7.11.3 Promega Corporation Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Promega Corporation Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.11.5 Promega Corporation Recent Development
7.12 Enzo Life Sciences, Inc
7.12.1 Enzo Life Sciences, Inc Company Information
7.12.2 Enzo Life Sciences, Inc Introduction and Business Overview
7.12.3 Enzo Life Sciences, Inc Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Enzo Life Sciences, Inc Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.12.5 Enzo Life Sciences, Inc Recent Development
7.13 Cole-Parmer
7.13.1 Cole-Parmer Company Information
7.13.2 Cole-Parmer Introduction and Business Overview
7.13.3 Cole-Parmer Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Cole-Parmer Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.13.5 Cole-Parmer Recent Development
7.14 Bioneer Corporation
7.14.1 Bioneer Corporation Company Information
7.14.2 Bioneer Corporation Introduction and Business Overview
7.14.3 Bioneer Corporation Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Bioneer Corporation Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.14.5 Bioneer Corporation Recent Development
7.15 Mylab Discovery Solutions
7.15.1 Mylab Discovery Solutions Company Information
7.15.2 Mylab Discovery Solutions Introduction and Business Overview
7.15.3 Mylab Discovery Solutions Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Mylab Discovery Solutions Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.15.5 Mylab Discovery Solutions Recent Development
7.16 Biom茅rieux S.A
7.16.1 Biom茅rieux S.A Company Information
7.16.2 Biom茅rieux S.A Introduction and Business Overview
7.16.3 Biom茅rieux S.A Reverse Transcription Polymerase Chain Reaction Kits Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Biom茅rieux S.A Reverse Transcription Polymerase Chain Reaction Kits Product Offerings
7.16.5 Biom茅rieux S.A Recent Development
8 Industry Chain Analysis
8.1 Reverse Transcription Polymerase Chain Reaction Kits Industrial Chain
8.2 Reverse Transcription Polymerase Chain Reaction Kits Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Reverse Transcription Polymerase Chain Reaction Kits Sales Model
8.5.2 Sales Channel
8.5.3 Reverse Transcription Polymerase Chain Reaction Kits Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Roche
Merck(Sigma-Aldrich)
Thermo Fisher Scientific
Qiagen N.V.
Meridian Bioscience
Takara Bio Inc
Agilent Technologies
Abbott Laboratories
Altona Diagnostics
Bio-Rad Laboratories
Promega Corporation
Enzo Life Sciences, Inc
Cole-Parmer
Bioneer Corporation
Mylab Discovery Solutions
Biom茅rieux S.A
听
听
*If Applicable.
